J Reconstr Microsurg 2024; 40(04): 253-261
DOI: 10.1055/a-2153-2285
Original Article

Muscle versus Fascia Free Tissue Transfer for Treatment of Chronic Osteomyelitis in the Comorbid Population

1   Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine, Washington, District of Columbia
2   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
,
2   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
3   Plastic and Reconstructive Surgery Division, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
,
1   Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine, Washington, District of Columbia
,
1   Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine, Washington, District of Columbia
2   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
,
Nisha J. Gupta
1   Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine, Washington, District of Columbia
,
Brian N. Truong
1   Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine, Washington, District of Columbia
,
Cameron M. Akbari
4   Department of Vascular Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
,
Karen K. Evans
2   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
› Author Affiliations
Funding None.

Abstract

Background In patients with chronic lower extremity (LE) wounds, chronic osteomyelitis confers additional complexity to achieving adequate treatment. Previous reviews demonstrate increased rates of osteomyelitis recurrence in patients who receive muscle flaps compared with fasciocutaneous flaps for LE limb salvage; however, these studies were not limited to atraumatic populations who receive exclusively free flaps. Thus, this study compared rates of recurrence in chronic osteomyelitis patients undergoing LE reconstruction with fasciocutaneous versus muscle free flaps.

Methods Patients undergoing free tissue transfer (FTT) between July 2011 and July 2021 were retrospectively reviewed. Patients were stratified into fasciocutaneous and muscle free flap groups. Primary outcomes included osteomyelitis recurrence, flap complications, limb salvage, and ambulatory status.

Results Forty-eight patients with pathologic diagnosis of chronic osteomyelitis of the wound bed were identified, of which 58.3% received fasciocutaneous (n = 28) and 41.7% received muscle flaps (n = 20). The most common comorbidities included diabetes mellitus (n = 29, 60.4%), peripheral neuropathy (n = 27, 56.3%) and peripheral vascular disease (n = 24, 50.0%). Methicillin-resistant or methicillin -sensitive Staphylococcus aureus were the most common pathogen in 18.7% (n = 9) of procedures. The majority of patients underwent a median of three debridements followed by negative pressure wound therapy prior to receiving FTT. At a median follow-up of 16.6 months, the limb salvage and ambulatory rates were 79.2 (n = 38) and 83.3% (n = 40), respectively. The overall rate of microsurgical flap success was 93.8% (n = 45). Osteomyelitis recurred in 25% of patients (n = 12) at a median duration of 4.0 months. There were no significant differences in rates of osteomyelitis recurrence, flap complications, limb salvage, ambulation, and mortality. On multivariate analysis, flap composition remained a nonsignificant predictor of osteomyelitis recurrence (odds ratio: 0.975, p = 0.973).

Conclusion This study demonstrates that flap composition may not influence recurrence of osteomyelitis following free flap reconstruction of chronic LE wounds, suggesting that optimal flap selection should be based on wound characteristics and patient goals.



Publication History

Received: 22 March 2023

Accepted: 31 July 2023

Accepted Manuscript online:
14 August 2023

Article published online:
25 September 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Panteli M, Giannoudis PV. Chronic osteomyelitis: what the surgeon needs to know. EFORT Open Rev 2017; 1 (05) 128-135
  • 2 Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364 (9431): 369-379
  • 3 Geraghty T, LaPorta G. Current health and economic burden of chronic diabetic osteomyelitis. Expert Rev Pharmacoecon Outcomes Res 2019; 19 (03) 279-286
  • 4 Kremers HM, Nwojo ME, Ransom JE, Wood-Wentz CM, Melton III LJ, Huddleston III PM. Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J Bone Joint Surg Am 2015; 97 (10) 837-845
  • 5 Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis. Am Fam Physician 2011; 84 (09) 1027-1033
  • 6 Chronic osteomyelitis: results obtained by an integrated team approach to management. | Read by QxMD. Accessed February 2, 2023 at: https://read.qxmd.com/read/15926634/chronic-osteomyelitis-results-obtained-by-an-integrated-team-approach-to-management
  • 7 Pande KC. Optimal management of chronic osteomyelitis: current perspectives. Orthop Res Rev 2015; 7: 71-81
  • 8 Whisstock C, Volpe A, Ninkovic S. et al. Multidisciplinary approach for the management and treatment of diabetic foot infections with a resorbable, gentamicin-loaded bone graft substitute. J Clin Med 2020; 9 (11) 1-18
  • 9 Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg 2004; 188 (1A, Suppl): 57-66
  • 10 Cierny III G. Surgical treatment of osteomyelitis. Plast Reconstr Surg 2011; 127 (1, Suppl 1): 190S-204S
  • 11 Barakat A, Schilling WH, Sharma S, Guryel E, Freeman R. Chronic osteomyelitis: a review on current concepts and trends in treatment. Orthop Trauma 2019; 33 (03) 181-187
  • 12 Chan JKK, Ferguson JY, Scarborough M, McNally MA, Ramsden AJ. Management of post-traumatic osteomyelitis in the lower limb: current state of the art. Indian J Plast Surg 2019; 52 (01) 62-72
  • 13 Piwnica-Worms W, Stranix JT, Othman S. et al. Risk factors for lower extremity amputation following attempted free flap limb salvage. J Reconstr Microsurg 2020; 36 (07) 528-533
  • 14 Kovar A, Colakoglu S, Iorio ML. Choosing between muscle and fasciocutaneous free flap reconstruction in the treatment of lower extremity osteomyelitis: available evidence for a function-specific approach. J Reconstr Microsurg 2020; 36 (03) 197-203
  • 15 Gonzalez MH, Weinzweig N. Muscle flaps in the treatment of osteomyelitis of the lower extremity. J Trauma 2005; 58 (05) 1019-1023
  • 16 Gosain A, Chang N, Mathes S, Hunt TK, Vasconez L. A study of the relationship between blood flow and bacterial inoculation in musculocutaneous and fasciocutaneous flaps. Plast Reconstr Surg 1990; 86 (06) 1152-1162 , discussion 1163
  • 17 Guzman-Stein G, Fix RJ, Vasconez LO. Muscle flap coverage for the lower extremity. Clin Plast Surg 1991; 18 (03) 545-552
  • 18 Richards RR, McKee MD, Paitich CB, Anderson GI, Bertoia JT. A comparison of the effects of skin coverage and muscle flap. J Bone Joint Surg Am 1991. Accessed February 2, 2023 at: https://journals.lww.com/jbjsjournal/Abstract/1991/73090/A_comparison_of_the_effects_of_skin_coverage_and.6.aspx
  • 19 Khatter AME, Elkabbani M, el Fahar MH. A retrospective comparative study between muscle flaps and fasciocutaneous flaps in reconstruction of chronic osteomyelitis related wounds of the lower limb in the adult population. Plast Reconstr Surg 2022; 46 (01) 37-43
  • 20 Dow T, ElAbd R, McGuire C. et al. Outcomes of free muscle flaps versus free fasciocutaneous flaps for lower limb reconstruction following trauma: a systematic review and meta-analysis. J Reconstr Microsurg 2023; 39 (07) 526-539
  • 21 Jorge LS, Fucuta PS, Oliveira MGL. et al. Outcomes and risk factors for polymicrobial posttraumatic osteomyelitis. J Bone Jt Infect 2018; 3 (01) 20-26
  • 22 Lavery LA, Peters EJG, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 2009; 83 (03) 347-352
  • 23 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
  • 24 DeFazio MV, Han KD, Akbari CM, Evans KK. Free tissue transfer after targeted endovascular reperfusion for complex lower extremity reconstruction: setting the stage for success in the presence of mutlivessel disease. Ann Vasc Surg 2015; 29 (06) 1316.e7-1316.e15
  • 25 Black C, Fan KL, Defazio MV. et al. Limb salvage rates and functional outcomes using a longitudinal slit arteriotomy end-to-side anastomosis for limb-threatening defects in a high-risk patient population. Plast Reconstr Surg 2020; 145 (05) 1302-1312
  • 26 Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis 2012; 54 (03) 393-407
  • 27 Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am 2004; 86 (10) 2305-2318
  • 28 Mathews JA, Ward J, Chapman TW, Khan UM, Kelly MB. Single-stage orthoplastic reconstruction of Gustilo-Anderson Grade III open tibial fractures greatly reduces infection rates. Injury 2015; 46 (11) 2263-2266
  • 29 Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003; 51 (05) 1261-1268
  • 30 Shimbo K, Kawamoto H, Koshima I. Muscle/musculocutaneous versus fasciocutaneous free flap reconstruction in the lower extremity: a systematic review and meta-analysis. Microsurgery 2022; 42 (08) 835-847
  • 31 Fox CM, Beem HM, Wiper J, Rozen WM, Wagels M, Leong JC. Muscle versus fasciocutaneous free flaps in heel reconstruction: systematic review and meta-analysis. J Reconstr Microsurg 2015; 31 (01) 59-66
  • 32 Cho EH, Shammas RL, Carney MJ. et al. Muscle versus fasciocutaneous free flaps in lower extremity traumatic reconstruction: a multicenter outcomes analysis. Plast Reconstr Surg 2018; 141 (01) 191-199
  • 33 Bovill JD, Sayyed AA, Huffman SS. et al. A comparative analysis of fasciocutaneous versus muscle free flaps in peripheral vascular disease patients. Microsurgery 2023; 43 (03) 253-260
  • 34 Seyidova N, Anderson K, Abood A. Comparison of patients satisfaction with aesthetic outcomes following lower extremity reconstruction: muscle vs. fasciocutaneous free flaps. J Plast Reconstr Aesthet Surg 2021; 74 (01) 65-70
  • 35 Yazar S, Lin CH, Lin YT, Ulusal AE, Wei FC. Outcome comparison between free muscle and free fasciocutaneous flaps for reconstruction of distal third and ankle traumatic open tibial fractures. Plast Reconstr Surg 2006; 117 (07) 2468-2475 , discussion 2476–2477
  • 36 Brady RA, Leid JG, Costerton JW, Shirtliff ME. Osteomyelitis: clinical overview and mechanisms of infection persistence. Clin Microbiol Newsl 2006; 28 (09) 65-72
  • 37 Mouzopoulos G, Kanakaris NK, Kontakis G, Obakponovwe O, Townsend R, Giannoudis PV. Management of bone infections in adults: the surgeon's and microbiologist's perspectives. Injury 2011; 42 (5, Suppl 5): S18-S23
  • 38 Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350 (14) 1422-1429
  • 39 Jensen LK, Koch J, Aalbaek B. et al. Early implant-associated osteomyelitis results in a peri-implanted bacterial reservoir. APMIS 2017; 125 (01) 38-45
  • 40 Osteomyelitis. StatPearls NCBI Bookshelf. Accessed February 2, 2023 at: https://www.ncbi.nlm.nih.gov/books/NBK532250/
  • 41 Hill SL, Holtzman GI, Buse R. The effects of peripheral vascular disease with osteomyelitis in the diabetic foot. Am J Surg 1999; 177 (04) 282-286
  • 42 Tan Y, Wang X, Li H. et al. The clinical efficacy of the vacuum-assisted closure therapy in the management of adult osteomyelitis. Arch Orthop Trauma Surg 2011; 131 (02) 255-259
  • 43 Conterno LO, Turchi MD. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev 2013; 2013 (09) CD004439